XML 42 R32.htm IDEA: XBRL DOCUMENT
v3.20.2

Organization and Nature of Operations (Details) | 6 Months Ended
--- | ---
Jun. 30, 2020
Avalon Healthcare System, Inc. (“AHS”) [Member] |
Organization and Nature of Operations (Textual) |
Place of Incorporation | Delaware
Date of Incorporation | May 18, 2015
Percentage of Ownership | 100.00%
Principal Activities | Provides medical related consulting services and developing Avalon Cell and Avalon Rehab in United States of America ("USA")
Avalon (BVI) Ltd. (“Avalon BVI”) [Member] |
Organization and Nature of Operations (Textual) |
Place of Incorporation | British Virgin Island
Date of Incorporation | Jan. 23, 2017
Percentage of Ownership | 100.00%
Principal Activities | Dormant, is in process of being dissolved
Avalon RT 9 Properties LLC (“Avalon RT 9”) [Member] |
Organization and Nature of Operations (Textual) |
Place of Incorporation | New Jersey
Date of Incorporation | Feb. 07, 2017
Percentage of Ownership | 100.00%
Principal Activities | Owns and operates an income-producing real property and holds and manages the corporate headquarters
Avalon (Shanghai) Healthcare Technology Co., Ltd. (“Avalon Shanghai”) [Member] |
Organization and Nature of Operations (Textual) |
Place of Incorporation | PRC
Date of Incorporation | Apr. 29, 2016
Percentage of Ownership | 100.00%
Principal Activities | Provides medical related consulting services and developing Avalon Cell and Avalon Rehab in China
Genexosome Technologies Inc. (“Genexosome”) [Member] |
Organization and Nature of Operations (Textual) |
Place of Incorporation | Nevada
Date of Incorporation | Jul. 31, 2017
Percentage of Ownership | 60.00%
Principal Activities | Develops proprietary diagnostic and therapeutic products using exosomes
Beijing Jieteng (Genexosome) Biotech Co., Ltd. ("Beijing Genexosome") [Member] |
Organization and Nature of Operations (Textual) |
Place of Incorporation | PRC
Date of Incorporation | Aug. 07, 2015
Percentage of Ownership | 100.00%
Principal Activities | Provides development services for hospitals and other customers and sells developed items to hospitals and other customers in China
Avactis Biosciences Inc. (''Avactis'') [Member] |
Organization and Nature of Operations (Textual) |
Place of Incorporation | Nevada
Date of Incorporation | Jul. 18, 2018
Percentage of Ownership | 100.00%
Principal Activities | Integrate and optimize global scientific and clinical resources to further advance cellular therapies, including regenerative medicine with stem/progenitor cells as well as cellular immunotherapy including CAR-T, CAR-NK, TCR-T and others to treat certain cancers
International Exosome Association LLC (''Exosome") [Member] |
Organization and Nature of Operations (Textual) |
Place of Incorporation | Delaware
Date of Incorporation | Jun. 13, 2019
Percentage of Ownership | 100.00%
Principal Activities | Promotes standardization related to exosome industry

X
- References No definition available. + Details
Name: | avco_EntityIncorporationsStateCountryName
Namespace Prefix: | avco_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | avco_OrganizationAndNatureOfOperationsTextualAbstract
Namespace Prefix: | avco_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Date when an entity was incorporated + References No definition available. + Details
Name: | dei_EntityIncorporationDateOfIncorporation
Namespace Prefix: | dei_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition A description of the principal activities of an investee accounted for under the equity method. + References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentDescriptionOfPrincipalActivities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | dei_LegalEntityAxis=avco_AvalonHealthcareSystemIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=avco_AvalonBVILtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=avco_AvalonRT9PropertiesLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=avco_AvalonShanghaiHealthcareTechnologyCoLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=avco_GenExosomeTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=avco_BeijingJietengGenExosomeBiotechCoLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=avco_AvactisBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=avco_InternationalExosomeAssociationLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |